CD52-directed Cytolytic Antibody [EPC]

19365 reported adverse events

Drugs of this class: ALEMTUZUMAB

These side effects are most commonly reported by patients taking drugs of the CD52-directed Cytolytic Antibody [EPC] class:

# Side effect Count
0 HEADACHE 1906
1 FATIGUE 1874
2 PYREXIA 1785
3 OFF LABEL USE 1698
4 RASH 1200
5 NAUSEA 1189
6 DRUG INEFFECTIVE 1032
7 DYSPNOEA 985
8 ASTHENIA 942
9 MULTIPLE SCLEROSIS RELAPSE 923
See all common reactions for CD52-directed Cytolytic Antibody [EPC]

Drugs of the CD52-directed Cytolytic Antibody [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BACTERIAL TEST 111 0.3725
1 CRYSTAL URINE PRESENT 187 0.3363
2 URINARY SEDIMENT PRESENT 201 0.3121
3 URINE LEUKOCYTE ESTERASE POSITIVE 218 0.3114
4 NITRITE URINE PRESENT 113 0.2580
5 RED BLOOD CELLS URINE POSITIVE 236 0.2441
6 LYMPHOCYTE PERCENTAGE DECREASED 249 0.1853
7 MONOCYTE PERCENTAGE INCREASED 118 0.1664
8 NEUTROPHIL PERCENTAGE INCREASED 209 0.1656
9 WHITE BLOOD CELLS URINE POSITIVE 292 0.1551
See all enriched reactions for CD52-directed Cytolytic Antibody [EPC]